268 related articles for article (PubMed ID: 27031231)
1. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.
Sondo P; Derra K; Diallo Nakanabo S; Tarnagda Z; Kazienga A; Zampa O; Valéa I; Sorgho H; Owusu-Dabo E; Ouédraogo JB; Guiguemdé TR; Tinto H
PLoS One; 2016; 11(3):e0151565. PubMed ID: 27031231
[TBL] [Abstract][Full Text] [Related]
2. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
4. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
6. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
[TBL] [Abstract][Full Text] [Related]
7. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
[TBL] [Abstract][Full Text] [Related]
9. In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Baraka V; Tinto H; Valea I; Fitzhenry R; Delgado-Ratto C; Mbonye MK; Van Overmeir C; Rosanas-Urgell A; Van Geertruyden JP; D'Alessandro U; Erhart A
Antimicrob Agents Chemother; 2015 Jan; 59(1):734-7. PubMed ID: 25403659
[TBL] [Abstract][Full Text] [Related]
10. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
[TBL] [Abstract][Full Text] [Related]
12. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
[TBL] [Abstract][Full Text] [Related]
14. Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.
Fröberg G; Jörnhagen L; Morris U; Shakely D; Msellem MI; Gil JP; Björkman A; Mårtensson A
Malar J; 2012 Sep; 11():321. PubMed ID: 22966778
[TBL] [Abstract][Full Text] [Related]
15. Selection of
Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
[TBL] [Abstract][Full Text] [Related]
16. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
17. Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.
Danquah I; Coulibaly B; Meissner P; Petruschke I; Müller O; Mockenhaupt FP
Acta Trop; 2010 Apr; 114(1):63-6. PubMed ID: 20060374
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
[TBL] [Abstract][Full Text] [Related]
20. pfmdr1 mutations in imported African Plasmodium falciparum isolates.
Dippmann AK; Bienzle U; Harms G; Mockenhaupt FP
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1148-50. PubMed ID: 18513774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
